Urinalysis Market by Product, Test Type, Application, End-Use

List of Tables

[187 Pages Report] The Urinalysis Market size was estimated at USD 4.30 billion in 2023 and expected to reach USD 4.53 billion in 2024, at a CAGR 5.76% to reach USD 6.37 billion by 2030.

Urinalysis is a test conducted on a urine sample and is commonly used for medical screening and diagnosis. The test encompasses various components that assess the urine's physical, chemical, and microscopic properties. By analyzing these properties, the test helps in detecting various disorders, such as urinary tract infections, kidney disease, and diabetes. The process typically involves three examinations: a visual exam, which observes the urine's color and clarity; a chemical exam, which tests chemically for substances such as protein, glucose, and blood; and a microscopic exam, which looks for cells, bacterial presence, and other elements that are not visible to the naked eye. The increasing incidence of kidney diseases and urinary tract infections globally leads to higher use of point-of-care urinalysis systems in clinical settings. These systems offer quick and efficient analysis, which propels their adoption in hospitals and labs, thus supporting the market's growth. However, the need for more awareness about the importance of regular health checkups and a shortage of skilled laboratory staff hinder the growth of the urinalysis market. The development of automated analyzers for detecting urinary tract infections represents a significant technological advancement, offering rapid and accurate testing. This improves patient care and opens up new opportunities for market expansion as healthcare providers increasingly adopt these efficient and reliable systems. These innovations are expected to propel market expansion by fulfilling the rising demand for timely and effective diagnostic solutions.

KEY MARKET STATISTICS
Base Year [2023]	USD 4.30 billion
Estimated Year [2024]	USD 4.53 billion
Forecast Year [2030]	USD 6.37 billion
CAGR (%)	5.76%

Regional Insights

In the Americas, particularly in the United States and Canada, the urinalysis market is robust due to the advanced healthcare infrastructure, high healthcare spending, and a strong focus on preventive care. The growing prevalence of chronic diseases, such as kidney disorders and diabetes requiring regular urine tests, contributes significantly to the market growth. Government and health organizations' initiatives to enhance diagnostic services support the expansion of the urinalysis market in this region. The Asia-Pacific region is showcasing rapid growth in the urinalysis market, driven by rising healthcare awareness, increasing population, and economic development in countries such as China and India. The Asia-Pacific region's large diabetic population, which requires frequent glucose level monitoring through urine tests, also propels market growth. In addition, the shift towards automated urinalysis systems due to labor constraints and the need for efficient healthcare solutions accentuates this growth. The urinalysis market in the EMEA region is showcasing growth owing to increasing healthcare awareness, advancements in diagnostic technologies, and a rising prevalence of diseases, including diabetes and urinary tract infections. EU funding for research in improving diagnostic technologies reflects a committed approach to enhancing healthcare outcomes across member states. The African urinalysis market is gradually growing with increased awareness about diseases such as urinary tract infections and diabetes.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Urinalysis Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Growing prevalence of kidney diseases and urinary tract infections worldwide
- Favorable government initiatives for early screening and management of chronic diseases
- Rising adoption of point-of-care urinalysis systems in clinical laboratories and hospitals

Market Restraints
- Significant concern for product recall

Market Opportunities
- Technological advancement in renal biomarker and smaRT-LAMP system
- Emergence of automated analyzers for urinary tract infection screening

Market Challenges
- Lack of awareness about routine health checkup and limited skilled laboratory workforce

Market Segmentation Analysis
- Product: Extensive use of collection cups for the simple and hygienic collection of urine samples for medical diagnostics
- End-Use: Increasing use in clinical laboratories for screening and diagnosing various disorders

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Urinalysis Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Urinalysis Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

AixMed and CorePlus Collaborate on Innovative Urine Analysis Research

AixMed partnered with CorePlus for an innovative study focusing on urine analysis to enhance diagnostic accuracy for various diseases. This partnership leverages CorePlus laboratories' capabilities and AixMed's expertise in medical diagnostics technology to revolutionize how diseases are detected and monitored potentially. This initiative aims to contribute valuable insights into disease mechanisms and patient health management. [Published On: 2024-04-18]

Toyoda Gosei Invests in Yuurea Inc. for Advancement in Urine Analysis Technology

Toyoda Gosei Co., Ltd. strategically invested in Yuurea Inc., an innovative startup specializing in the development of urine test kits aimed at early detection of eating disorders. Yuurea Inc.'s urine test kits represent a significant advancement in medical diagnostics, offering a non-invasive and timely method for identifying potential eating disorders, thereby facilitating earlier intervention and treatment. [Published On: 2024-03-25]

Medtronic's Strategic Initiative to Address Urinary Incontinence with New Venture

Medtronic, a medical technology, service, and solutions provider, recently unveiled a new venture specifically aimed at advancing treatments for urinary incontinence, expanding its portfolio in medical technology solutions. This develops the company's commitment to address widespread health concerns by investing in innovative and effective treatments. [Published On: 2023-04-03]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Urinalysis Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Urinalysis Market, highlighting leading vendors and their innovative profiles. These include 77 Elektronika Kft., Abbott Laboratories, ACON Laboratories, Inc. by Inverness Medical, AdvaCare Pharma, Alphatec Scientific E.I.R.L., Analyticon Biotechnologies GmbH by BRAIN Biotech AG, Anamol Laboratories Pvt. Ltd., ARKRAY, Inc., Beckman Coulter, Inc. by Danaher Corporation, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Bioway Biotechnology Co., Ltd., Cardinal Health, Inc., Contec Medical Systems Co., Ltd., Dirui Industrial Co., Ltd., EKF DIAGNOSTICS HOLDINGS PLC, Erba Group, F. Hoffmann-La Roche Ltd., Kova International, Inc. by LGC Limited, MACHEREY-NAGEL GmbH & Co. KG, Medsource Ozone Biomedicals Pvt. Ltd., Quidel Corporation, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthcare GmbH, Sweet Cures Nutra, Sysmex Corporation, Teco Diagnostics, Thermo Fisher Scientific Inc., URIT Medical Electronic Group Co., Ltd, and Woodley Equipment Company Ltd..

Market Segmentation & Coverage

This research report categorizes the Urinalysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Consumables
  - Collection Cups
  - Reagents
  - Urine Strips/Dipsticks

Instruments

Test Type
- Biochemical Urinalysis
- Pregnancy & Fertility Tests
- Sediment Urinalysis

Application
- Diabetes
- Hypertension
- Kidney Diseases
- Liver Diseases
- Urinary Tract Infections

End-Use
- Clinical Laboratories
- Home Healthcare
- Hospitals
- Research & Academics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-034B5003034D

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing prevalence of kidney diseases and urinary tract infections worldwide
  - 5.1.1.2. Favorable government initiatives for early screening and management of

chronic diseases

5.1.1.3. Rising adoption of point-of-care urinalysis systems in clinical laboratories and hospitals

5.1.2. Restraints
- 5.1.2.1. Significant concern for product recall
5.1.3. Opportunities
- 5.1.3.1. Technological advancement in renal biomarker and smaRT-LAMP system
- 5.1.3.2. Emergence of automated analyzers for urinary tract infection screening
5.1.4. Challenges
- 5.1.4.1. Lack of awareness about routine health checkup and limited skilled laboratory workforce

5.2. Market Segmentation Analysis
- 5.2.1. Product: Extensive use of collection cups for the simple and hygienic collection of urine samples for medical diagnostics
- 5.2.2. End-Use: Increasing use in clinical laboratories for screening and diagnosing various disorders
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Urinalysis Market, by Product

6.1. Introduction
6.2. Consumables
6.3. Instruments

7. Urinalysis Market, by Test Type

7.1. Introduction
7.2. Biochemical Urinalysis
7.3. Pregnancy & Fertility Tests
7.4. Sediment Urinalysis

8. Urinalysis Market, by Application

8.1. Introduction
8.2. Diabetes
8.3. Hypertension
8.4. Kidney Diseases
8.5. Liver Diseases
8.6. Urinary Tract Infections

9. Urinalysis Market, by End-Use

9.1. Introduction
9.2. Clinical Laboratories
9.3. Home Healthcare
9.4. Hospitals
9.5. Research & Academics

10. Americas Urinalysis Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Urinalysis Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Urinalysis Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. AixMed and CorePlus Collaborate on Innovative Urine Analysis Research
- 13.3.2. Toyoda Gosei Invests in Yuurea Inc. for Advancement in Urine Analysis Technology
- 13.3.3. Medtronic's Strategic Initiative to Address Urinary Incontinence with New Venture
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio